Biondvax Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Biondvax Pharmaceuticals (SCNI) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Biondvax Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Biondvax Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Biondvax Pharmaceuticals by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $10 | 8 | 1.25 |
| 2025-06-30 | $28k | 12k | 2.28 |
| 2025-03-31 | $40k | 15k | 2.69 |
| 2024-12-31 | $79k | 24k | 3.35 |
| 2024-09-30 | $104 | 30 | 3.47 |
| 2024-06-30 | $583 | 211 | 2.77 |